OnKure Therapeutics, Inc.

Nasdaq:OKUR

Pharmaceutical Preparations·BOULDER, CO

Financials

20 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	11/6/25	→
10-Q	Q2 2025	6/30/25	8/12/25	→
10-Q	Q1 2025	3/31/25	5/6/25	→
10-K	FY 2024	12/31/24	3/10/25	→
10-Q	Q3 2024	9/30/24	11/7/24	→
10-Q	Q2 2024	6/30/24	8/13/24	→
↓

Earnings Releases (8-K)

19 shown

Filed	Period
11/6/25	Q4 FY2025	→
8/12/25	Q3 FY2025	→
5/6/25	Q2 FY2025	→
3/10/25	Q1 FY2025	→
8/13/24	Q3 FY2024	→
5/7/24	Q2 FY2024	→
↓

News (8-K)

29 shown

Filed	Type	Description
11/6/25	Agreement	Entry into a Material Definitive Agreement	→
6/26/25	Reg FD	Regulation FD Disclosure	→
5/28/25	Vote	Submission of Matters to a Vote of Security Holders	→
12/10/24	Reg FD	Regulation FD Disclosure	→
11/7/24	Other	Changes in Registrant's Certifying Accountant	→
10/8/24	Acquisition	Completion of Acquisition or Disposition of Assets	→
↓

Prospectuses & Registrations

34 shown

Filed	Form	Description
11/21/25	424B3	424B3	→
11/6/25	S-3	S-3	→
11/6/25	424B3	424B3	→
8/12/25	424B3	424B3	→
5/28/25	424B3	424B3	→
5/6/25	424B3	424B3	→
↓

Filing History(340 filings)

TypeDateAccessionPeriodSize

SCHEDULE 13G

Feb 17, 2026

0001104659-26-016660

—

18.8 KB

SCHEDULE 13G/A

Feb 17, 2026

0001104659-26-016541

—

17.9 KB

SCHEDULE 13G/A

Feb 17, 2026

0000902664-26-001088

—

9.1 KB

SCHEDULE 13G/A

Jan 30, 2026

0000102909-26-000240

—

7.0 KB

Jan 2, 2026

0001193125-26-0009424

Dec 31, 2025

4.7 KB

Jan 2, 2026

0001622769-26-000001

Dec 31, 2025

5.0 KB

Dec 23, 2025

0001609284-25-000004

Dec 22, 2025

5.8 KB

Dec 23, 2025

0001692747-25-000004

Dec 22, 2025

5.8 KB

SCHEDULE 13G

Nov 28, 2025

0001104659-25-116660

—

35.4 KB

424B3

Nov 21, 2025

0001193125-25-291362424B3

—

218.6 KB

EFFECT

Nov 18, 2025

9999999995-25-003308

—

1.8 KB

POS AM

Nov 6, 2025

0001193125-25-270150POS AM

—

285.5 KB

S-3

Nov 6, 2025

0001193125-25-270073S-3

—

1.2 MB

424B3

Nov 6, 2025

0001193125-25-269724424B3

—

3.1 MB

8-K

Nov 6, 2025

0001193125-25-2696528-K

Nov 6, 2025

668.7 KB

10-Q

Nov 6, 2025

0001193125-25-26954010-Q

Sep 30, 2025

7.7 MB

8-K

Nov 6, 2025

0001193125-25-2694688-K

Nov 6, 2025

387.9 KB

Oct 2, 2025

0001193125-25-2284024

Sep 30, 2025

4.7 KB

Oct 2, 2025

0001622769-25-000003

Sep 30, 2025

5.0 KB

Sep 24, 2025

0001609284-25-000003

Sep 22, 2025

5.6 KB

Sep 24, 2025

0001692747-25-000003

Sep 22, 2025

5.6 KB

SCHEDULE 13G/A

Aug 14, 2025

0001415889-25-021974

—

11.0 KB

SCHEDULE 13G/A

Aug 14, 2025

0000950170-25-109073

—

9.7 KB

SCHEDULE 13G

Aug 14, 2025

0000902664-25-003640

—

8.9 KB

SCHEDULE 13G

Aug 14, 2025

0001213900-25-076638

—

25.4 KB

25 filings shown

Filed	Form	Description
4/16/25	DEFA14A	DEFA14A	→
4/16/25	DEF 14A	DEF 14A	→
4/26/23	DEFA14A	DEFA14A	→
4/26/23	DEF 14A	DEF 14A	→
4/22/22	DEFA14A	DEFA14A	→
4/22/22	DEF 14A	DEF 14A	→

OnKure Therapeutics, Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(340 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
1/2/26	4	4	→
1/2/26	4	4	→
12/23/25	4	4	→
12/23/25	4	4	→
10/2/25	4	4	→
10/2/25	4	4	→
↓

Filed	Form	Description
2/17/26	SCHEDULE 13G	SCHEDULE 13G	→
2/17/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
2/17/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
1/30/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
11/28/25	SCHEDULE 13G	SCHEDULE 13G	→
11/18/25	EFFECT	EFFECT	→
↓